Cutler Group LP Medicinova Inc Call Options Transaction History

Cutler Group LP

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Jan 18, 2022	SELL	$2.61 - $4.42 $30,015 - $50,830	-11,500 Reduced 69.7%	5,000 $0
Q3 2021 Oct 26, 2021	BUY	$3.4 - $4.24 $40,800 - $50,880	12,000 Added 266.67%	16,500 $2,000
Q2 2021 Jul 19, 2021	BUY	$3.76 - $5.14 $15,040 - $20,560	4,000 Added 800.0%	4,500 $0
Q1 2021 Apr 26, 2021	BUY	$4.81 - $8.74 $2,405 - $4,370	500 New	500 $0
Q4 2020 Jan 21, 2021	SELL	$5.03 - $6.31 $4,024 - $5,048	-800 Closed	0 $0
Q3 2020 Oct 27, 2020	BUY	$4.67 - $11.0 $3,736 - $8,800	800 New	800 $0
Q2 2018 Aug 10, 2018	SELL	$7.96 - $13.23 $1,592 - $2,646	-200 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$6.6 - $13.91 $35,640 - $75,114	-5,400 Reduced 96.43%	200 $0
Q4 2017 Jan 17, 2018	BUY	$5.89 - $7.21 $26,505 - $32,445	4,500 Added 409.09%	5,600 $2,000
Q3 2017 Oct 17, 2017	BUY	$4.43 - $6.58 $4,873 - $7,238	1,100	1,100 $0

4.83M

9.4K

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $88.3M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.